Skip to main content
Triochem Products Ltd. logo

Triochem Products Ltd. — Investor Relations & Filings

Ticker · 512101 ISIN · INE331E01013 BSE.NS Manufacturing
Open in API
Filings indexed 442 across all filing types
Latest filing 2023-11-04 Regulatory Filings
Country IN India
Listing BSE.NS 512101

About Triochem Products Ltd.

https://www.triochemproducts.com

Triochem Products Ltd. is a manufacturer and exporter specializing in Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. The company focuses on the production of high-quality chemical compounds for the global healthcare and pharmaceutical sectors. Its core product portfolio includes a range of specialized substances such as Quinine salts, Quinidine salts, and other niche therapeutic ingredients. Triochem Products Ltd. emphasizes adherence to stringent quality control measures and international regulatory standards to ensure the efficacy and safety of its chemical outputs. The organization serves a diverse clientele, providing essential raw materials for the formulation of various medications. By leveraging advanced chemical synthesis processes and technical expertise, the company maintains a significant presence in the supply chain for specialized pharmaceutical components.

Recent filings

Filing Released Lang Actions
This is to inform you that Disclosure of he Related Party Trassaction on a consolidated basis under Regualtion 23(9) of SEBI (LODR) (Amendment) Regualtion 2018 is not applicable to our Compnay.
Regulatory Filings
2023-11-04 English
Statement of deviation or variation in public issue, rights issure, prederential issue, etc. for the quarter ened 30th September 2023
Regulatory Filings Classification · 100% confidence The document text is extremely short (188 characters) and contains only digital signature information without any substantive content or financial data. There is no indication of a report, announcement, or detailed filing. Given the lack of content, this document does not fit any specific report category and defaults to the fallback category for miscellaneous filings.
2023-11-04 English
We wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Saturday 4th November 2023 have inter-alia considered and approved the Unaduited Standalone ....
Regulatory Filings
2023-11-04 English
We would like to inform you that, pursuant to Notice of Board meeting dated 26th October 2023 the Board Meeting of the Company was held today Saturday 4th November 2023 at 2.00 p.m. at ....
Regulatory Filings
2023-11-04 English
In complaince to Regualtion 47 of SEBI (LODR) Regualtion 2015. Notice of Board Meeting of the Company schedule to ne held on Saturday 4th November 2023 published in Navshakti and Free Press ....
Regulatory Filings Classification · 95% confidence The document is a letter from Triochem Products Limited addressed to BSE Limited, referencing compliance with Regulation 47 of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. It mentions enclosing copies of the Notice of the upcoming Board Meeting scheduled for 4th November 2023, which was published in newspapers on 27th October 2023. The document is an announcement informing the stock exchange and public about the notice publication for a board meeting. There is no substantive financial data, management discussion, or detailed report content. The document is relatively short and serves as an announcement of a notice publication rather than the notice itself or any financial report. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-10-27 English
TRIOCHEM PRODUCTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2023 ,inter alia, to consider and approve Pursuant to the provision ....
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve the unaudited financial results for the quarter and half year ended 30th September 2023. It is an intimation under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing the stock exchange about the upcoming board meeting. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is a short notice informing about the meeting and the agenda, including the approval of financial results. Therefore, it is not an Interim/Quarterly Report (IR) or Earnings Release (ER), but rather a Regulatory Filing (RNS) as a general regulatory announcement about the board meeting and financial results approval.
2023-10-26 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.